Forde PM - Search Results

1

Crizotinib in the treatment of non-small-cell lung cancer.

Forde PM, Rudin CM. Forde PM, et al. Expert Opin Pharmacother. 2012 Jun;13(8):1195-201. doi: 10.1517/14656566.2012.688029. Expert Opin Pharmacother. 2012. PMID: 22594847 Review.

2

Targeted therapy for non-small-cell lung cancer: past, present and future.

Forde PM, Ettinger DS. Forde PM, et al. Expert Rev Anticancer Ther. 2013 Jun;13(6):745-58. doi: 10.1586/era.13.47. Expert Rev Anticancer Ther. 2013. PMID: 23773106 Free PMC article. Review.

3

Tumor lysis syndrome in limited-stage small-cell lung cancer.

Boikos SA, Forde PM, Chatterjee S, Hann CL. Boikos SA, et al. Among authors: forde pm. J Thorac Oncol. 2013 Jul;8(7):e61-2. doi: 10.1097/JTO.0b013e318286bb3b. J Thorac Oncol. 2013. PMID: 23774387 Free article. No abstract available.

4

What lies within: novel strategies in immunotherapy for non-small cell lung cancer.

Forde PM, Reiss KA, Zeidan AM, Brahmer JR. Forde PM, et al. Oncologist. 2013;18(11):1203-13. doi: 10.1634/theoncologist.2013-0171. Epub 2013 Oct 8. Oncologist. 2013. PMID: 24105749 Free PMC article. Review.

5

New strategies in lung cancer: translating immunotherapy into clinical practice.

Forde PM, Kelly RJ, Brahmer JR. Forde PM, et al. Clin Cancer Res. 2014 Mar 1;20(5):1067-73. doi: 10.1158/1078-0432.CCR-13-0731. Epub 2014 Jan 27. Clin Cancer Res. 2014. PMID: 24470514 Review.

6

Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief report.

Forde PM, Hooker CM, Boikos SA, Petrini I, Giaccone G, Rudin CM, Yang SC, Illei PB, Hann CL, Ettinger DS, Brahmer JR, Kelly RJ. Forde PM, et al. J Thorac Oncol. 2014 Mar;9(3):414-8. doi: 10.1097/JTO.0000000000000065. J Thorac Oncol. 2014. PMID: 24518093 Free PMC article.

7

New strategies in lung cancer: epigenetic therapy for non-small cell lung cancer.

Forde PM, Brahmer JR, Kelly RJ. Forde PM, et al. Clin Cancer Res. 2014 May 1;20(9):2244-8. doi: 10.1158/1078-0432.CCR-13-2088. Epub 2014 Mar 18. Clin Cancer Res. 2014. PMID: 24644000 Free PMC article. Review.

8

Antagonists of PD-1 and PD-L1 in Cancer Treatment.

Lipson EJ, Forde PM, Hammers HJ, Emens LA, Taube JM, Topalian SL. Lipson EJ, et al. Among authors: forde pm. Semin Oncol. 2015 Aug;42(4):587-600. doi: 10.1053/j.seminoncol.2015.05.013. Epub 2015 Jun 10. Semin Oncol. 2015. PMID: 26320063 Free PMC article. Review.

9

Managing acquired resistance in EGFR-mutated non-small cell lung cancer.

Forde PM, Ettinger DS. Forde PM, et al. Clin Adv Hematol Oncol. 2015 Aug;13(8):528-32. Clin Adv Hematol Oncol. 2015. PMID: 26351816 Review.

10

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer.

Anagnostou V, Smith KN, Forde PM, Niknafs N, Bhattacharya R, White J, Zhang T, Adleff V, Phallen J, Wali N, Hruban C, Guthrie VB, Rodgers K, Naidoo J, Kang H, Sharfman W, Georgiades C, Verde F, Illei P, Li QK, Gabrielson E, Brock MV, Zahnow CA, Baylin SB, Scharpf RB, Brahmer JR, Karchin R, Pardoll DM, Velculescu VE. Anagnostou V, et al. Among authors: forde pm. Cancer Discov. 2017 Mar;7(3):264-276. doi: 10.1158/2159-8290.CD-16-0828. Epub 2016 Dec 28. Cancer Discov. 2017. PMID: 28031159 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters